Adamis Pharmaceuticals

Patent cliffs & loss of exclusivity

A biopharmaceutical company developing products for the treatment of respiratory disease and allergy

Company

AngelList URLhttps://angel.co/adamis-pharmaceuticals
Business ModelCommerce
CAGE Code6G5P4
Company Operating StatusActive
Contact Page URLhttps://www.adamispharmaceuticals.com/contact-us/
Crunchbase URLhttps://www.crunchbase.com/organization/adamis-pharmaceuticals
Full Address11682 El Camino Real, Suite 300, San Diego, CA 92130, US
Legal Entity Identifier549300EBMD9JZ2H87I37

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. SYMJEPIEPINEPHRINESmall mol.Oct 2036
  2. SYMJEPIEPINEPHRINESmall mol.Oct 2036

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Adamis Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio